Search

Your search keyword '"Drummond, Daryl C"' showing total 272 results

Search Constraints

Start Over You searched for: Author "Drummond, Daryl C" Remove constraint Author: "Drummond, Daryl C"
272 results on '"Drummond, Daryl C"'

Search Results

1. Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic.

3. New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model

4. Discovery of internalizing antibodies to basal breast cancer cells

5. Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting

8. Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts

9. Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models

10. Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine

12. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model

13. Supplementary Data from Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models

14. Data from Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models

15. Supplementary Tables 1 - 3 from Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High SLFN11 Expression

16. Figure S4 from Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study

17. Data from Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High SLFN11 Expression

18. Supplemental Information from Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study

37. Specificity of soluble phospholipid binding sites on human factor X(sub)a

38. Phosphatidylserine binding alters the conformation and specifically enhances the cofactor activity of bovine factor V (sub)a

40. Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models

45. Analysis of Single-Cell RNA-Seq Identifies Cell-Cell Communication Associated with Tumor Characteristics

49. Antibody-mediated targeting of TNFR2 activates CD8 + T cells in mice and promotes antitumor immunity

Catalog

Books, media, physical & digital resources